SeaCrest Wealth Management’s Boston Scientific BSX Stock Holding History

SeaCrest Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,821	Closed	-$142K	–	750
2022 Q2	$142K	Buy	+3,821	New	+$156K	0.02%	731
2019 Q2	–	Sell	-1,204	Closed	-$46K	–	693
2019 Q1	$46K	Buy	1,204 +465	+63%	+$17.8K	0.01%	963
2018 Q4	$26K	Sell	739 -622	-46%	-$22.6K	0.01%	1127
2018 Q3	$52K	Buy	1,361 +123	+10%	+$4.3K	0.01%	982
2018 Q2	$40K	Sell	1,238 -25	-2%	-$754	0.01%	1069
2018 Q1	$35K	Hold	1,263	–	–	0.01%	1095
2017 Q4	$31K	Buy	+1,263	New	+$34.8K	0.01%	1165

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

SeaCrest Wealth Management's BSX Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 3,821 shares — an estimated $142K sold.

SeaCrest Wealth Management first reported a position in BSX in Q4 2017 and held it in 7 quarters. The position peaked at $142K in Q2 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

SeaCrest Wealth Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
SeaCrest Wealth Management sold 3,821 Boston Scientific shares in Q3 2022, an estimated $142K.
SeaCrest Wealth Management first reported a position in Boston Scientific in Q4 2017 and held it in 7 quarters.
SeaCrest Wealth Management's Boston Scientific position peaked at $142K in Q2 2022.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.